rxstat › Classes › Antipsychotics

Antipsychotics: shortage status in Canada

11 of the 18 antipsychotics rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Periciazine (Neuleptil) Widespread shortage 2 of 4 reported products affected Trifluoperazine Widespread shortage 5 of 5 reported products affected Aripiprazole (Abilify) Partial shortage 3 of 29 reported products affected Haloperidol Partial shortage 6 of 16 reported products affected Lithium Carbonate (Carbolith) Partial shortage 4 of 11 reported products affected · est. return Jan 1, 2027 Loxapine (Xylac) Partial shortage 4 of 10 reported products affected Lurasidone (Latuda) Partial shortage 1 of 19 reported products affected · est. return Aug 7, 2026 Olanzapine (Zyprexa) Partial shortage 3 of 106 reported products affected · est. return Aug 14, 2026 Quetiapine (Seroquel) Partial shortage 47 of 117 reported products affected · est. return Dec 31, 2026 Risperidone Partial shortage 17 of 81 reported products affected · est. return Aug 7, 2026 Ziprasidone (Zeldox) Partial shortage 2 of 8 reported products affected Chlorpromazine No current shortage Clozapine No current shortage Fluphenazine No current shortage Methotrimeprazine (Methoprazine) No current shortage Perphenazine No current shortage Pimozide (Orap) Discontinued 0 of 2 reported products affected Prochlorperazine No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.